Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ultra Nasdaq Biotechnology 2X ETF (NQ: BIB )

55.48 +1.74 (+3.25%)
Streaming Delayed Price Updated: 11:09 AM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ultra Nasdaq Biotechnology 2X ETF

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. 
Via InvestorPlace
The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities
These are some of the best ETFs to buy heading into New Year 2023. Not only do they offer solid diversification, but they're cheap. 
Via InvestorPlace
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year. 
Via InvestorPlace
Market Briefing For Tuesday, July 5, 2022
This is a complicated time. Everything is bifurcated. Stocks. The political backdrop. Society itself. 
Via Talk Markets
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: 
Via Benzinga
Friday Trades And June Summary
Trading performance has been very good year to date. I had thought I needed to tighten my belt but I made it by just fine. 
Via Talk Markets
Take A Look At The Top-Performing Biotech ETFs YTD
The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq... 
Via Talk Markets
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.